Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
Portland |
| State: |
|
Oregon |
| Zip Code: |
|
|
| Conditions: |
|
Alopecia - Alopecia, Androgenetic - Baldness |
| Purpose: |
|
This study will evaluate the safety and efficacy of 3 doses of bimatoprost solution compared
with vehicle and over-the-counter (OTC) minoxidil 5% solution in men with androgenic
alopecia. All treatments will be provided in a double-blinded fashion except for minoxidil
5% solution which will be provided open-label.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Mild to moderate male pattern baldness (androgenic alopecia) with ongoing hair loss
for at least 1 year
- Willingness to have micro-dot-tattoo applied to scalp
- Willingness to maintain same hair style, length and hair color during study
Exclusion Criteria:
- Drug or alcohol abuse within 12 months
- HIV positive
- Received hair transplants or had scalp reductions
- Use of hair weaves, hair extensions or wigs within 3 months
- Oral or topical minoxidil treatment within 6 months
- Application of topical steroids or nonsteroidal anti-inflammatory drugs (NSAIDs) to
scalp within 4 weeks
|
| NCT ID: |
|
NCT01325337 |
| Primary Contact: |
|
Study Director
Medical Director
Allergan
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Portland, Oregon
United States
There is no listed contact information for this specific location.
Site Status: N/A |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|